Perform Another (Advanced) Search

1. Clinical Trial Results by Drug Names
...Drug Names Clinical Trial Result Information Title of Study: Pharmacokinetic Study of Herceptin® (H) and Doxorubicin (A) plus Paclitaxel (T) followed by weekly Paclitaxel (AT+/-H→TH) in Women with Metastatic ...
...randomized, open study to investigate the efficacy, safety and pharmacokinetics of combination treatment with Herceptin, doxorubicin and paclitaxel. Study center(s) : 5 centers in Germany, Italy and Spain. Objectives: Primary: To ...
View Page

2.  CenterWatch: Clinical Trials in Category (197) Liver Cancer
...of Dasatinib (BMS354825) in Advanced Hepatocellular Carcinoma Duarte : Local Institution Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer Loma Linda : Loma Linda University Cancer Center Comparison ...
...Subjects Who Have Failed Sorafenib Treatment Los Angeles : Local Institution Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer Los Angeles : Local Institution Study of BMS-582664 ...
View Page

3.  Newly Approved Drug Therapies (541) Doxil (doxorubicin HCl liposome injection), Alza,
...Newly Approved Drug Therapies (541) Doxil (doxorubicin HCl liposome injection), Alza, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Doxil (doxorubicin HCl liposome injection) Company: Alza Approval Status: Approved June 1999 Treatment Area: Oncology General Information ...
View Page

4.  Study Posting (180) Trial #88173, Multiple Myelomas, New York, NY
...Trial #88173, Multiple Myelomas, New York, NY Trial Information Phase I/II Study of Liposomal Doxorubicin (Doxil®)/ Melphalan/ Bortezomib (Velcade®) in Relapsed/Refractory Multiple Myeloma The goals of this study are to examine a investigational combination of chemotherapy drugs including liposomal doxorubicin (Doxil®), melphalan, and bortezomib (Velcade®) and to see if this combination is safe and effective ...
View Page

5.  Study Posting (1918) Trial #160141, Kidney Cancer, Savannah, GA
...Study Posting (1918) Trial #160141, Kidney Cancer, Savannah, GA Trial Information Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing ...
...III Wilms' Tumor COG AREN0532 RATIONALE: Drugs used in chemotherapy, such as vincristine, dactinomycin, and doxorubicin, work in different ways to stop the growth of tumor cells, either by killing the ...
View Page

6.  CenterWatch: Clinical Trials in Category (95) Lymphomas
...2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular Lymphoma Arizona Peoria : Merck Clinical trial ...
...2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular Lymphoma Duarte : City of Hope New ...
View Page

7.  Study Posting (2348) Trial #85475, Endometrial Cancer, New York, NY
...Trial #85475, Endometrial Cancer, New York, NY Trial Information A Randomized Phase III Trial of Doxorubicin/Cisplatin/Paclitaxel and G-CSF versus Carboplatin/Paclitaxel in Patients with Stage III & IV or ...
...carboplatin and paclitaxel is as good as the current standard three-drug combination of cisplatin, doxorubicin, and paclitaxel. Study participants will be randomly assigned (by chance) to receive either the 2 ...
View Page

8.  Study Posting (797) Trial #158460, Breast Cancer, Elgin, Il
...158460, Breast Cancer, Elgin, Il Trial Information E5103 “A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive ...
...by the name of bevacizumab to the current standard chemotherapy of cancer-reducing medications, namely doxorubicin, cyclophosphamide and paclitaxel, reduces the risk of recurrence (called disease-free survival) compared to standard ...
View Page

9.  Study Posting (4694) Trial #140873, Breast Cancer, Poughkeepsie, NY
...Breast Cancer, Poughkeepsie, NY Trial Information ECOG 5103 - "A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive ...
...node positive and high risk lymph node negative breast cancer randomized to treatment with either doxorubicin/cyclophosphamide plus placebo followed by paclitaxel (AC +placebo >T + placebo) or the same chemotherapy regimen ...
View Page

10.  Study Posting (1819) Trial #158246, Leukemia, Cincinnati, OH
...of Obatoclax (Pan Anti-Apoptotic BCL-2 Family Small Molecule Inhibitor), in Combination with Vincristine/Doxorubicin/Dexrazoxane, in Children with Relapsed/Refractory Solid Tumors or Leukemia What is the purpose of ...
...To find the highest safe dose of obatoclax that can be given with chemotherapy (vincristine, doxorubicin, and dexrazoxane) without causing severe side effects • To learn what kind of side effects obatoclax ...
View Page

11.  Study Posting (1819) Trial #158245, Solid Tumors, Cincinnati, OH
...of Obatoclax (Pan Anti-Apoptotic BCL-2 Family Small Molecule Inhibitor), in Combination with Vincristine/Doxorubicin/Dexrazoxane, in Children with Relapsed/Refractory Solid Tumors or Leukemia What is the purpose of ...
...To find the highest safe dose of obatoclax that can be given with chemotherapy (vincristine, doxorubicin, and dexrazoxane) without causing severe side effects • To learn what kind of side effects obatoclax ...
View Page

12.  Study Posting (2246) Trial #126203, Non-Hodgkin's Lymphoma, Duarte, CA
...Information SWOG S0433: Iodine-131 Labeled Monoclonal Antibody (I-131 Tositumomab) in Combination with Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Rituximab Therapy for Patients With Advanced Stage Diffuse Large B Cell NHL ...
...s Lymphoma). The purpose of this study is to evaluate rituximab and chemotherapy with cyclophosphamide, doxorubicin (hydroxydoxorubicin), vincristine (Oncovin®), and prednisone (R-CHOP) followed by Iodine-131 (I-131) tositumomab in ...
View Page

13.  Study Posting (4576) Trial #106166, Liver Cancer, Taipei, Taiwan
...Posting (4576) Trial #106166, Liver Cancer, Taipei, Taiwan Trial Information Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer The purpose of this clinical research study is ...
...FDA, pharmaceutical, Liver Cancer description: CenterWatch Clinical Research Trial Posting: Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer ...
View Page

14.  Study Posting (4576) Trial #106167, Liver Cancer, Tainan, Taiwan
...Posting (4576) Trial #106167, Liver Cancer, Tainan, Taiwan Trial Information Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer The purpose of this clinical research study is ...
...FDA, pharmaceutical, Liver Cancer description: CenterWatch Clinical Research Trial Posting: Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer ...
View Page

15.  Study Posting (4576) Trial #106165, Liver Cancer, Singapore, Singapore
...Posting (4576) Trial #106165, Liver Cancer, Singapore, Singapore Trial Information Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer The purpose of this clinical research study is ...
...FDA, pharmaceutical, Liver Cancer description: CenterWatch Clinical Research Trial Posting: Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer ...
View Page

16.  Study Posting (4576) Trial #106164, Liver Cancer, Singapore, Singapore
...Posting (4576) Trial #106164, Liver Cancer, Singapore, Singapore Trial Information Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer The purpose of this clinical research study is ...
...FDA, pharmaceutical, Liver Cancer description: CenterWatch Clinical Research Trial Posting: Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer ...
View Page

17.  Study Posting (4576) Trial #106161, Liver Cancer, Quezon, Philippines
...Posting (4576) Trial #106161, Liver Cancer, Quezon, Philippines Trial Information Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer The purpose of this clinical research study is ...
...FDA, pharmaceutical, Liver Cancer description: CenterWatch Clinical Research Trial Posting: Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer ...
View Page

18.  Study Posting (4576) Trial #106148, Liver Cancer, Villejuif, France
...Posting (4576) Trial #106148, Liver Cancer, Villejuif, France Trial Information Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer The purpose of this clinical research study is ...
...FDA, pharmaceutical, Liver Cancer description: CenterWatch Clinical Research Trial Posting: Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer ...
View Page

19.  Study Posting (4576) Trial #106149, Liver Cancer, Rennes, France
...Posting (4576) Trial #106149, Liver Cancer, Rennes, France Trial Information Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer The purpose of this clinical research study is ...
...FDA, pharmaceutical, Liver Cancer description: CenterWatch Clinical Research Trial Posting: Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer ...
View Page

20.  Study Posting (4576) Trial #106150, Liver Cancer, Marseille, France
...Posting (4576) Trial #106150, Liver Cancer, Marseille, France Trial Information Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer The purpose of this clinical research study is ...
...FDA, pharmaceutical, Liver Cancer description: CenterWatch Clinical Research Trial Posting: Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer ...
View Page